Curing blindness via WET is an ambitious goal with significant barriers. An important limitation to the field's ability to make meaningful advancements despite incredible work being performed all around the world is, in part, because researchers tend to work in silos. Thankfully, government institutions, including the National Eye Institute (Audacious Goals initiative) and ARPA-H (The Human Eye Allotransplant initiative), provide funding opportunities to fast-track innovation and collaboration on these issues. Think tanks like RReSTORe bring disparate researchers to the same table for unified discussion. What is incredible about these efforts is that they are accelerating new, multi-disciplinary, convergent collaborations. Ultimately, optic regeneration will require a complex, combinatorial approach in which axon growth is supported, guidance cues are given, the immune system is modulated, axons are remyelinated, and brain connectivity is supported. Different clinical expertise, from ophthalmology to transplant surgery to neurosurgery to immunology, must be combined before realizing the potential of moonshot approaches like WET.